$LGND
Ligand Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
$295.54
▼-0.99%-$2.96
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLigand Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is LGND down today? It is at $295.54 (-0.99%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LGND spikes, and full due diligence on LGND — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LGND 27 times in the last 30 days. Create a free account to track $LGND, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LGND from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LGND today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Oct 7, 2026 · 11 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Reardon Andrew Officer | Sold (automatic/other) | -5K 0.03% of company | sold 14% | 32K | $1.5M at $302.51 | Oct 2, 26 |
Reardon Andrew Officer | Other | 340 | added 0.9% | 37K | $18K at $52.27 | Oct 2, 26 |
Zimmermann Martine Director | Sold (automatic/other) | -115 | sold 3.0% | 4K | $34K at $298.50 | Sep 22, 26 |
Zimmermann Martine Director | Sold (automatic/other) | -1K | sold 24% | 4K | $342K at $285.00 | Sep 10, 26 |
Reardon Andrew Officer | Sold (automatic/other) | -5K 0.03% of company | sold 12% | 37K | $1.4M at $283.99 | Sep 3, 26 |
Haas Jason Director | Sold (automatic/other) | -7K 0.04% of company | sold 64% | 4K | $2.1M at $292.81 | Aug 12, 26 |
Haas Jason Director | Other | 6K 0.03% of company | added 100% | 11K | $316K at $51.56 | Aug 12, 26 |
Espinoza Octavio Officer | Sold (automatic/other) | -32K 0.2% of company | sold 53% | 28K | $9.2M at $292.06 | Aug 12, 26 |
Espinoza Octavio Officer | Other | 32K 0.2% of company | added 100% | 59K | $1.7M at $52.84 | Aug 12, 26 |
Reardon Andrew Officer | Sold (automatic/other) | -5K 0.03% of company | sold 11% | 42K | $1.4M at $284.14 | Aug 3, 26 |
Reardon Andrew Officer | Other | 5K 0.03% of company | added 12% | 47K | $261K at $52.27 | Aug 3, 26 |
Reardon Andrew Officer | Sold (automatic/other) | -5K 0.03% of company | sold 11% | 42K | $1.5M at $308.99 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LGND from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LGND today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LGND last traded at $295.54, down 0.99% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Ligand Pharmaceuticals Inc. (LGND) is next expected to report earnings on Thursday, October 29, 2026 (before open), about 11 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LGND Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LGND 27 times in the last 30 days.
LGND (Ligand Pharmaceuticals Inc.) trades on XNAS, with a market cap of about $5.89B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LGND for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LGND discussion
Sign in to ask a question or join the discussion.